We motivate 60.000 patients in finland to take control of their own oral anticoagulation therapy

More than 2.000.000 patients in Europe are living on long-term oral anticoagulation. ISMAAP activities are focussed around these patients to offer them a better quality of life.

This web site contains comprehensive information about this subject, as well as information about living with lifelong anticoagulation.

In the name of the authors, we would like to thank you for taking interest in these subjects. Managing Board of the ISMAAP, Geneva.